Scientists at the University of Toronto's Leslie Dan Faculty of Pharmacy have seen remarkable success combining tumor modulating nanoparticles with doxorubicin to enhance chemotherapy response in pre-clinical model breast cancer. This combination approach also appears to boost anti-tumor immunity, contributing to the growing excitement surrounding immunotherapy as an avenue to treat cancer.
In 2014, a dengue outbreak unexpectedly occurred in Tokyo. What does that mean for the 2020 summer Olympics and Paralympics being held in the city? Researchers report this week in PLOS Neglected Tropical Diseases that new controls and frameworks are recommended to detect dengue and other infectious diseases and help prevent their spread during the summer games.
Results of a 275-patient, multi-national phase III clinical trial known as ALTA-1L published in the New England Journal of Medicine and presented concurrently in the press program at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer 2018 argue for brigatinib as a first-line treatment option for advanced ALK-positive non-small cell lung cancer.
Efforts to contain the latest Ebola outbreak in Democratic Republic of Congo are being threatened by a "perfect storm" of challenges, including rebel violence and pre-election turbulence, the UN said.
Researchers found that antibiotics actually kill the 'good' bacteria keeping infection and inflammation at bay. New research shows that the body's own microbes are effective in maintaining immune cells and killing certain oral infections.
Patients with meningococcal infection generally develop symptoms including a high temperature, vomiting and a stiff neck. But they might also just have a bad stomach ache. This can be so severe that they are sometimes wrongly operated for appendicitis. Researchers decided to investigate the question. And the results speak for themselves: 10% of patients infected by the meningococcal strain that is on the rise in Europe suffer from abdominal pain.
Ten treatable traits in people with severe asthma can help predict asthma attacks, say authors of a study published online in Respirology.
Garmin International, Inc., a unit of Garmin Ltd., today announced the vívofit jr. 2 kid's fitness tracker with Marvel's Spider-Man themed bands and mobile app. So much more than a fitness device, the vívofit jr. 2 provides kids with an interactive experience where activity unlocks adventure, shaping habits for lifelong health and fitness. In an engaging, comic book-style Spider-Verse app experience, kids will look forward to crushing activity minute goals to unlock new adventures, games, gems and step icons.